Answers are grounded in this paper and cite their sources.
Two series of novel coumarin derivatives, substituted at 3 and 7 positions with aminoalkoxy groups, are synthesized, characterized, and screened. The effect of amine substituents and the length of cross‐linker are investigated in acetyl‐ and butyrylcholinesterase (AChE and BuChE) inhibition. Target compounds show moderate to potent inhibitory activities against AChE and BuChE. 3‐(3,4‐Dichlorophenyl)‐7‐[4‐(diethylamino)butoxy]‐2 H ‐chromen‐2‐one ( 4y ) is identified as the most potent compound against AChE (IC 50 =0.27 μ m ). Kinetic and molecular modeling studies affirmed that compound 4y works in a mixed‐type way and interacts simultaneously with the catalytic active site (CAS) and peripheral anionic site (PAS) of AChE. In addition, compound 4y blocks β‐amyloid (Aβ) self‐aggregation with a ratio of 44.11 % at 100 μ m and significantly protects PC12 cells from H 2 O 2 ‐damage in a dose‐dependent manner.
No takes yet. Share an insight, caveat, or question.
Abdshahzadeh et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: